SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis
SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis
Not yet recruiting · NCT06772363 · Registry updated 2025-03-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not stated | 2025-03-31 | NCT06772363 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fuzhou General Hospital | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Raman detector | Fuzhou | China | 1 |